ProHealth introduced Essentials NMN 500, a 500 mg nicotinamide mononucleotide supplement using an amorphous formulation claimed to enhance bioavailability, priced at $24.95 for 30 capsules. Published research supports that NMN supplementation raises blood NAD+ levels within the 250-1,200 mg dose range, though direct clinical comparison data between formulation types remains limited.
Key Points
- NMN supplementation elevates blood NAD+ at 250-1,200 mg doses
- Amorphous formulation claims faster dissolution and improved absorption
- Independent comparative data between formulations not yet established
Longevity Analysis
NAD+ availability declines with age and directly influences metabolic efficiency, mitochondrial function, and the capacity for cellular repair—core mechanisms underlying healthy aging. The regulatory clarification on NMN's dietary supplement status removes uncertainty that previously limited clinical evaluation and consumer access. Cost-accessible supplementation at this dosage enables broader investigation into whether formulation type meaningfully affects NAD+ bioavailability in longer-term protocols, an open question necessary to optimize dosing strategies for energy production and regeneration across diverse populations.
Original published by LT Wire.